Sanofi Clears Cancer Drug From More Generic Competition

By Andrew Karpan · June 28, 2023, 7:30 PM EDT

A federal judge in Delaware has come down on the side of Sanofi in the major drugmaker's efforts to assert one of the newer patents it landed on a blockbuster drug...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Sanofi-Aventis U.S. LLC, et al. v. Sandoz Inc.

Case Number

1:20-cv-00804

Court

Delaware

Nature of Suit

Patent - Abbreviated New Drug Application(ANDA)

Date Filed

June 12, 2020